Mushroom poisoning in infants and children: the Amanita pantherina/muscaria group.
The clinical features and management of nine cases of mushroom poisoning due to Amanita pantherina (eight cases) and Amanita muscaria (one case) admitted to a children's hospital are described. Most ingestions were in the toddler age group with males being more frequently involved. Symptoms occurred between 30-180 min with the onset of central nervous system depression, ataxia, waxing and waning obtundation, hallucinations, intermittent hysteria or hyperkinetic behavior. Vomiting was rare. Seizures or myoclonic twitching occurred in 4/9 patients, but was controlled with standard anticonvulsant therapy. No other anticholinergic or cholinergic signs were prominent. Recovery was rapid and complete in all patients.
Department of Laboratories, Children's Hospital and Medical Center, University of Washington, Seattle 98105.
D R
DR
Benjamin
D000293:Adolescent; D000367:Age Factors; D000545:Amanita; D002606:Charcoal / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005751:Gastric Lavage; D006801:Humans; D007223:Infant; D007486:Ipecac / Q000627:therapeutic use; D008297:Male; D009145:Mushroom Poisoning / Q000453:epidemiology* / Q000628:therapy; D010634:Phenobarbital / Q000627:therapeutic use; D012189:Retrospective Studies; D012737:Sex Factors; D014861:Washington / Q000453:epidemiology
D002606:Charcoal; D007486:Ipecac; D003975:Diazepam; D010634:Phenobarbital